Patents by Inventor Per Gjorstrup

Per Gjorstrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating ototoxicity
    Patent number: 9987244
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ototoxicity, by administering these compounds or pharmaceutical compositions to subjects in need thereof. Ototoxicity is defined as damage to the structures of the ear, such as the cochlea and vestibular system, by drugs or toxins. Ototoxicity can result in irreversible hearing loss, tinnitus, dysequilibrium, Meniere's disease, or vertigo.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: June 5, 2018
    Assignee: ANIDA PHARMA, INC.
    Inventor: Per Gjorstrup
  • Methods of Treating Ototoxicity
    Publication number: 20170105957
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ototoxicity, by administering these compounds or pharmaceutical compositions to subjects in need thereof. Ototoxicity is defined as damage to the structures of the ear, such as the cochlea and vestibular system, by drugs or toxins. Ototoxicity can result in irreversible hearing loss, tinnitus, dysequilibrium, Meniere's disease, or vertigo.
    Type: Application
    Filed: September 23, 2016
    Publication date: April 20, 2017
    Inventor: Per Gjorstrup
  • Methods of treating ototoxicity
    Patent number: 9468620
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ototoxicity, by administering these compounds or pharmaceutical compositions to subjects in need thereof. Ototoxicity is defined as damage to the structures of the ear, such as the cochlea and vestibular system, by drugs or toxins. Ototoxicity can result in irreversible hearing loss, tinnitus, dysequilibrium, Meniere's disease, or vertigo.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: October 18, 2016
    Assignee: Andida Pharma, Inc.
    Inventor: Per Gjorstrup
  • Methods of treating amyotrophic lateral sclerosis
    Patent number: 9340483
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ALS, by administering these compounds or pharmaceutical compositions to subjects in need thereof.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: May 17, 2016
    Assignee: ANIDA PHARMA INC.
    Inventor: Per Gjorstrup
  • Compositions and methods for the treatment of inflammation
    Patent number: 9315447
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: April 19, 2016
    Assignee: A.T. RESOLVE SARL
    Inventors: Per Gjorstrup, C. Eric Schwartz
  • METHODS OF TREATING OTOTOXICITY
    Publication number: 20160000742
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ototoxicity, by administering these compounds or pharmaceutical compositions to subjects in need thereof. Ototoxicity is defined as damage to the structures of the ear, such as the cochlea and vestibular system, by drugs or toxins. Ototoxicity can result in irreversible hearing loss, tinnitus, dysequilibrium, Meniere's disease, or vertigo.
    Type: Application
    Filed: February 26, 2014
    Publication date: January 7, 2016
    Inventor: Per GJORSTRUP
  • Methods of Treating Amyotrophic Lateral Sclerosis
    Publication number: 20150010549
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ALS, by administering these compounds or pharmaceutical compositions to subjects in need thereof.
    Type: Application
    Filed: February 15, 2013
    Publication date: January 8, 2015
    Applicant: ANIDA PHARMA INC.
    Inventor: Per Gjorstrup
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION
    Publication number: 20140275247
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: A.T. Resolve Sarl
    Inventors: Per Gjorstrup, C. Eric Schwartz
  • Compositions and methods for the treatment of inflammation
    Patent number: 8673881
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Grant
    Filed: April 13, 2010
    Date of Patent: March 18, 2014
    Assignee: A.T. Resolve Sarl
    Inventors: Per Gjorstrup, C. Eric Schwartz
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
    Publication number: 20130316989
    Abstract: The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: August 5, 2013
    Publication date: November 28, 2013
    Applicant: RESOLVYX PHARMACEUTICALS, INC.
    Inventor: Per Gjorstrup
  • COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION
    Publication number: 20120122816
    Abstract: The invention relates to reducing, preventing or reversing organ damage, reducing and/or preventing stem cell damage and/or death, enhancing organ preservation and/or survival, or enhancing stem cell preservation and/or survival comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, an oxylipin compound, or a combination of aspirin and an omega-3 fatty acid.
    Type: Application
    Filed: February 5, 2010
    Publication date: May 17, 2012
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION
    Publication number: 20120101061
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Application
    Filed: April 13, 2010
    Publication date: April 26, 2012
    Inventors: Per Gjorstrup, C. Eric Schwartz
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
    Publication number: 20110190242
    Abstract: The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: September 23, 2009
    Publication date: August 4, 2011
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS
    Publication number: 20100035989
    Abstract: The invention relates to methods of treating mucositis comprising administering a compound of formula A, compound of any one of formulae 1 to 46, lipoxin compound, or oxylipin compound.
    Type: Application
    Filed: July 19, 2007
    Publication date: February 11, 2010
    Inventors: C. Eric Schwartz, Per Gjorstrup
  • Compositions and methods for modulating immune function
    Publication number: 20090137527
    Abstract: The invention relates to methods of modulating immune function, suppressing immune response, treating autoimmune diseases or autoimmune disorders, and treating diseases, sequelae or pathological conditions mediated by an activation of the immune system comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: September 12, 2008
    Publication date: May 28, 2009
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventors: Per Gjorstrup, Shixin Qin, Lijun Wu
  • Compositions and methods for the treatment of ophthalmic conditions
    Publication number: 20090118243
    Abstract: The invention relates to methods of treating ophthalmic conditions comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: October 10, 2008
    Publication date: May 7, 2009
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • Compounds and methods for inhibition of bone loss
    Publication number: 20080161274
    Abstract: The invention relates to methods of treating or preventing bone loss, as in osteoporosis, metastatic bone disease, or periodontitis, comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: October 26, 2007
    Publication date: July 3, 2008
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventors: Per Gjorstrup, Matthew James Nichols
  • Compositions and methods for the treatment of inflammatory disease
    Publication number: 20080161275
    Abstract: The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: December 5, 2007
    Publication date: July 3, 2008
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • Compositions and methods for the treatment of cardiovascular disease
    Publication number: 20070254897
    Abstract: The invention relates to methods of treating cardiovascular disease comprising administering a resolvin, lipoxin, or oxylipin compound.
    Type: Application
    Filed: April 27, 2007
    Publication date: November 1, 2007
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • Methods of treating ototoxicity
    Patent number: RE48077
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ototoxicity, by administering these compounds or pharmaceutical compositions to subjects in need thereof. Ototoxicity is defined as damage to the structures of the ear, such as the cochlea and vestibular system, by drugs or toxins. Ototoxicity can result in irreversible hearing loss, tinnitus, dysequilibrium, Meniere's disease, or vertigo.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: July 7, 2020
    Assignee: Anida Pharma Inc.
    Inventor: Per Gjorstrup